©
2004 - 2008 |
||||||||||||||
|
|
- Adjuvant
Therapy of Stage III and IV Malignant Melanoma Using Granulocyte-Macrophage
Colony-Stimulating Factor (PDF)
- Low-Dose
Outpatient Chemobiotherapy With Temozolomide, Granulocyte-Macrophage
Colony Stimulating Factor, Interferon-aplha2b, and Recombinant Interleukin-2
for the Treatment of Metastatic Melanoma (PDF)
- Noninterferon-based
Adjuvant Therapy for High Risk Melanoma (PDF)
- Value of Alpha Interferon in Adjuvant Therapy for Melanoma: The Case Against (PDF)
